Hu, Lin
Huang, Qi
Huang, Shiqiong
Feng, Zeying
Article History
Received: 21 April 2023
Accepted: 7 July 2023
First Online: 17 July 2023
Declarations
:
: This study strictly followed the Helsinki Declaration, and the protocol was approved by the Institutional Review Board of Xiangya Hospital (approval number 2018091069).
: Written informed consent was obtained from all participants for the TDM of VRC, the measurement of CYP2C19 phenotype, and the use of their data.
: The identity information of all patients was coded to ensure privacy was not compromised.
: The authors have declared that no competing interests exist.